TNGX Earnings

Quarterly EPS
$-0.27
Q3 2024
$-0.34
Q4 2024
$-0.36
Q1 2025
$-0.35
Q2 2025
$0.14
Q3 2025
$-0.29
Q4 2025
$-0.32
Q1 2026
$-0.37
Q2 2026
Latest RevenueN/A
Latest Net Income-55341000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.370-55341000-100.0%-5.7%
Q1 2026-$0.320-45514000-100.0%+11.1%
Q4 2025-$0.290-38749000-100.0%+14.7%
Q3 2025$0.1453.8M15.9M+363.6%+151.9%
Q2 2025-$0.353.2M-38853000-84.0%-45.8%
Q1 2025-$0.365.4M-39876000-16.7%-2.9%
Q4 2024-$0.344.1M-37670000-24.2%-17.2%
Q3 2024-$0.2711.6M-29167000+8.2%-17.4%
Q2 2024-$0.2419.9M-25551000
Q1 2024-$0.356.5M-37914000
Q4 2023-$0.295.4M-30763000
Q3 2023-$0.2310.7M-22263000
Tango Therapeutics (TNGX) — Earnings